AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36088325 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea and coffee (Staining agents)
Number of subjects: 80
Study 36088325 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (Staining agent)
Number of subjects: 80
Study 33878164 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolved protein-protein interaction (PPI) networks
Number of subjects: 0
Study 33878164 — intervention group
Group type: COMPARATOR
Intervention: Random deletion of proteins
Number of subjects: 0
Study 33878164 — intervention group
Group type: COMPARATOR
Intervention: Random deletion of proteins restricted to those disrupted in LTEE
Number of subjects: 0
Study 35933278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week PrEP with human diploid cell culture rabies vaccine (HDCV) IM (Group 1)
Number of subjects: 570
Study 35933278 — intervention group
Group type: COMPARATOR
Intervention: 3-week PrEP with human diploid cell culture rabies vaccine (HDCV) IM (Group 2)
Number of subjects: 570
Study 35933278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week PrEP with HDCV ID (Group 3)
Number of subjects: 570
Study 35933278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week PrEP with Vero cell rabies vaccine (PVRV) IM (Group 4)
Number of subjects: 570
Study 35933278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week PrEP with Vero cell rabies vaccine (PVRV) ID (Group 5)
Number of subjects: 570
Study 35933278 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups after simulated PEP
Number of subjects: 570
Study 32471382 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified FOLFIRINOX for 3 months
Number of subjects: 574
Study 32471382 — intervention group
Group type: COMPARATOR
Intervention: RCT (Cap50 intensified-modulated radiotherapy)
Number of subjects: 574
Study 35669363 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump therapy
Number of subjects: 422
Study 35669363 — intervention group
Group type: COMPARATOR
Intervention: Oral hypoglycemic drugs or diet control, appropriate exercise
Number of subjects: 422
Study 34100843 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological anticoagulation
Number of subjects: 1776
Study 34100843 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 1776
Study 32620184 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime sleep complaints (sleep quality and refreshment)
Number of subjects: 332
Study 32620184 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime dysfunction (fatigue, sleepiness, and difficulty concentrating)
Number of subjects: 332
Study 32620184 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 332
Study 35963558 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (d-methylphenidate + guanfacine)
Number of subjects: 172
Study 35963558 — intervention group
Group type: EXPERIMENTAL
Intervention: D-methylphenidate
Number of subjects: 172
Study 35963558 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 172
Study 33714191 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (combined resistance and aerobic training, 40-60 min, 4 days/week for 12 weeks)
Number of subjects: 35
Study 32820324 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA using oesophageal probes (SensiTherm™) in OPERA+ group
Number of subjects: 180
Study 32820324 — intervention group
Group type: COMPARATOR
Intervention: RFA using fixed energy levels of 25 W in OPERA- group
Number of subjects: 180
Study 32820324 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 180
Study 35368384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 5 mg twice per day
Number of subjects: 432
Study 35368384 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 432
Study 33019874 — intervention group
Group type: EXPERIMENTAL
Intervention: PEMs from Cancer Care Ontario (CCO)
Number of subjects: 80
Study 33019874 — intervention group
Group type: EXPERIMENTAL
Intervention: PEMs from BC Cancer (BCC)
Number of subjects: 80
Study 33019874 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody-based therapies (PEMs from BCC)
Number of subjects: 80
Study 33019874 — intervention group
Group type: EXPERIMENTAL
Intervention: Small molecule-based therapies (PEMs from BCC)
Number of subjects: 80
Study 36181554 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital therapeutic app delivering cognitive behavioral therapy (BT‐001)
Number of subjects: 669
Study 36181554 — intervention group
Group type: COMPARATOR
Intervention: Control app
Number of subjects: 669
Study 33549004 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care education and training program
Number of subjects: 72
Study 33549004 — intervention group
Group type: COMPARATOR
Intervention: Standardized training only (Control)
Number of subjects: 72
Study 32866625 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and Trastuzumab (TH)
Number of subjects: 1770
Study 32866625 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline/Cyclophosphamide/Taxane/Trastuzumab (ACTH) or Taxane/Carboplatin/Trastuzumab (TCH)
Number of subjects: 1770
Study 34509310 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide sutures
Number of subjects: 112
Study 34509310 — intervention group
Group type: COMPARATOR
Intervention: Chromic gut sutures
Number of subjects: 112
Study 32192020 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension Tamer (TT) app
Number of subjects: 30
Study 32192020 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle education program delivered via smartphone (SPCTL)
Number of subjects: 30
Study 35048657 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 112
Study 35048657 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot snare polypectomy (HSP)
Number of subjects: 112
Study 35048657 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC)
Number of subjects: 112
Study 35048657 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 112
Study 32672489 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib (IM) and hydroxyurea (HU) combination therapy
Number of subjects: 137
Study 32672489 — intervention group
Group type: COMPARATOR
Intervention: Imatinib (IM) monotherapy
Number of subjects: 137
Study 36291230 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz t‐VNS in the auricular concha area
Number of subjects: 30
Study 36291230 — intervention group
Group type: COMPARATOR
Intervention: Periauricular area (control group)
Number of subjects: 30
Study 36435838 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored lifestyle and intensively supplemented with oral nutrition support (Group SS)
Number of subjects: 0
Study 36435838 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (Group NN)
Number of subjects: 0
Study 33952426 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic limb length of 200 cm
Number of subjects: 210
Study 33952426 — intervention group
Group type: COMPARATOR
Intervention: Biliopancreatic limb length of 50 cm
Number of subjects: 210
Study 33237906 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor recreational activity experiences
Number of subjects: 0
Study 33237906 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36396298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pudendal nerve block
Number of subjects: 155
Study 36396298 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided dorsal penile nerve block
Number of subjects: 155
Study 33307998 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon beta-1a
Number of subjects: 0
Study 33307998 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 33307998 — intervention group
Group type: EXPERIMENTAL
Intervention: sNfL levels
Number of subjects: 0
Study 33307998 — intervention group
Group type: EXPERIMENTAL
Intervention: active MS
Number of subjects: 0
Study 33187167 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper cervical translatoric mobilization
Number of subjects: 78
Study 33187167 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory suboccipital technique
Number of subjects: 78
Study 33187167 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 35072578 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Cognitive Behavioral Therapy (CBT)
Number of subjects: 148
Study 35072578 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Cognitive Behavioral Therapy (CBT)
Number of subjects: 148
Study 33588644 — intervention group
Group type: EXPERIMENTAL
Intervention: Copenhagen Adduction Exercise (CAE)
Number of subjects: 200
Study 33588644 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Hamstring Exercise (NHE)
Number of subjects: 200
Study 33588644 — intervention group
Group type: EXPERIMENTAL
Intervention: Copenhagen Adduction Exercise + Nordic Hamstring Exercise (CAE + NHE)
Number of subjects: 200
Study 33588644 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 34244463 — intervention group
Group type: EXPERIMENTAL
Intervention: Child perspective videos
Number of subjects: 106
Study 34244463 — intervention group
Group type: COMPARATOR
Intervention: Adult perspective videos
Number of subjects: 106
Study 33428233 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 40 ppm
Number of subjects: 15
Study 33428233 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normoxic gas)
Number of subjects: 15
Study 32507560 — intervention group
Group type: EXPERIMENTAL
Intervention: DetectNet
Number of subjects: 550
Study 32507560 — intervention group
Group type: EXPERIMENTAL
Intervention: AlexNet
Number of subjects: 550
Study 32507560 — intervention group
Group type: EXPERIMENTAL
Intervention: VGG-16
Number of subjects: 550
Study 32507560 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without ISTs)
Number of subjects: 550
Study 36121664 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate screening at age 45
Number of subjects: 46495
Study 36121664 — intervention group
Group type: COMPARATOR
Intervention: Deferred screening at age 50
Number of subjects: 46495
Study 36121664 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group (both arms)
Number of subjects: 46495
Study 36121664 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-initiated PSA tests
Number of subjects: 46495
Study 36121664 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with a history of digital rectal examination or PSA testing
Number of subjects: 46495
Study 34529714 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention engaging traditional and religious leaders
Number of subjects: 0
Study 34529714 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent scale-up of the intervention
Number of subjects: 0
Study 32297776 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching intervention (six-session positive psychology-based)
Number of subjects: 59
Study 32297776 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 59
Study 36146909 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention targeting parents (informational handouts and videos about health effects of juice and SSBs)
Number of subjects: 144
Study 36146909 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 144
Study 36146909 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention targeting parents
Number of subjects: 144
Study 34718462 — intervention group
Group type: EXPERIMENTAL
Intervention: POC EID (on-site testing with the Alere q HIV-1/2 Detect)
Number of subjects: 4000
Study 34718462 — intervention group
Group type: COMPARATOR
Intervention: SOC EID (enhanced standard of care, off-site testing at a public laboratory)
Number of subjects: 4000
Study 32730026 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered intervention
Number of subjects: 297
Study 32730026 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered plus telephone intervention
Number of subjects: 297
Study 32730026 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 297
Study 35928565 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed Circuit Training (MCT)
Number of subjects: 7
Study 35928565 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 7
Study 32391627 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-layered silicone foam dressings
Number of subjects: 422
Study 32391627 — intervention group
Group type: COMPARATOR
Intervention: Standard prevention (Control)
Number of subjects: 422
Study 35763112 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance classes for 22 weeks
Number of subjects: 49
Study 34412668 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) for 40 min on a cycle ergometer at 60% of HR reserve
Number of subjects: 39
Study 34412668 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE) for 40 min at 60% 1-RM
Number of subjects: 39
Study 34412668 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise (CE) for 20 min RE + 20 min AE
Number of subjects: 39
Study 34412668 — intervention group
Group type: EXPERIMENTAL
Intervention: α1-adrenergic blocker (doxazosin 0.05 mg/kg)
Number of subjects: 39
Study 34412668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 32993607 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Workplace Participatory Program (HWPP)
Number of subjects: 6
Study 32993607 — intervention group
Group type: COMPARATOR
Intervention: Lagged intervention (no immediate HWPP intervention)
Number of subjects: 6
Study 35791670 — intervention group
Group type: EXPERIMENTAL
Intervention: ABO-compatible cryoprecipitate
Number of subjects: 363
Study 35791670 — intervention group
Group type: COMPARATOR
Intervention: ABO-incompatible cryoprecipitate
Number of subjects: 363
Study 34855613 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media recruitment (paid advertisements on Facebook, Instagram, and Grindr)
Number of subjects: 414
Study 34855613 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram recruitment
Number of subjects: 414
Study 34855613 — intervention group
Group type: EXPERIMENTAL
Intervention: Grindr recruitment
Number of subjects: 414
Study 34855613 — intervention group
Group type: COMPARATOR
Intervention: Venue-based recruitment (clubs, bars, community centers, AIDS service organizations)
Number of subjects: 414
Study 35862109 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1656
Study 35862109 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1656
Study 33588490 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigated screw fixation
Number of subjects: 36
Study 33588490 — intervention group
Group type: COMPARATOR
Intervention: Conventional screw fixation
Number of subjects: 36
Study 34775476 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding progression (feeding day 2)
Number of subjects: 51
Study 34775476 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding progression (feeding day 5)
Number of subjects: 51
Study 33769117 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (0.5–1.25 mg/day)
Number of subjects: 0
Study 33769117 — intervention group
Group type: COMPARATOR
Intervention: IFNβ‐1a–fingolimod switch group
Number of subjects: 0
Study 33769117 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous fingolimod
Number of subjects: 0
Study 34344316 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care educational intervention (intensive four-day training and one-day follow-up sessions every four months, with illustrated educational leaflets)
Number of subjects: 186
Study 34344316 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 186
Study 32075015 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark Chocolate (DC)
Number of subjects: 98
Study 32075015 — intervention group
Group type: COMPARATOR
Intervention: White Chocolate (WC)
Number of subjects: 98
Study 35276329 — intervention group
Group type: EXPERIMENTAL
Intervention: 130 mg ustekinumab
Number of subjects: 961
Study 35276329 — intervention group
Group type: EXPERIMENTAL
Intervention: approximately 6 mg/kg ustekinumab
Number of subjects: 961
Study 35276329 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 961
Study 35276329 — intervention group
Group type: EXPERIMENTAL
Intervention: ustekinumab groups
Number of subjects: 961
Study 32107609 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg intravenously every 2 weeks)
Number of subjects: 59
Study 32107609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 32686617 — intervention group
Group type: EXPERIMENTAL
Intervention: elotuzumab
Number of subjects: 0
Study 32686617 — intervention group
Group type: EXPERIMENTAL
Intervention: ixazomib
Number of subjects: 0
Study 32686617 — intervention group
Group type: EXPERIMENTAL
Intervention: daratumumab
Number of subjects: 0
Study 32686617 — intervention group
Group type: EXPERIMENTAL
Intervention: panobinostat
Number of subjects: 0
Study 36428083 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised high‐intensity exercise training programme
Number of subjects: 169
Study 36428083 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 169
Study 34117162 — intervention group
Group type: EXPERIMENTAL
Intervention: modified directly administered ART (mDAART) plus standard of care
Number of subjects: 50
Study 34117162 — intervention group
Group type: COMPARATOR
Intervention: standard of care alone
Number of subjects: 50
Study 33001136 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab with or without Tremelimumab
Number of subjects: 0
Study 33001136 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 0
Study 35627346 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot group A (30% body weight support)
Number of subjects: 24
Study 35627346 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot group B (50% body weight support)
Number of subjects: 24
Study 35627346 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot group C (70% body weight support)
Number of subjects: 24
Study 33132112 — intervention group
Group type: EXPERIMENTAL
Intervention: HAVISA health messages in television advertisements for unhealthy foods
Number of subjects: 100
Study 33132112 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health messages)
Number of subjects: 100
Study 32410400 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine alone
Number of subjects: 0
Study 32410400 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine combined with sildenafil citrate
Number of subjects: 0
Study 32410400 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33958719 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine milk-based infant formula with 7.2 g MOS/L
Number of subjects: 115
Study 33958719 — intervention group
Group type: COMPARATOR
Intervention: Control group (bovine milk-based, alpha-lactalbumin, and sn-2 palmitate enriched infant formula)
Number of subjects: 115
Study 34188460 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing program (30 minutes per session, two sessions per day for seven consecutive days)
Number of subjects: 224
Study 34188460 — intervention group
Group type: COMPARATOR
Intervention: Therapist-led rehabilitation (same timing and frequency as experimental group)
Number of subjects: 224
Study 34188460 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing program
Number of subjects: 224
Study 34188460 — intervention group
Group type: COMPARATOR
Intervention: Therapist-led rehabilitation
Number of subjects: 224
Study 34188460 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing program and therapist-led rehabilitation
Number of subjects: 224
Study 32273276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cy/GVAX followed by CRS-207 with nivolumab (Arm A)
Number of subjects: 93
Study 32273276 — intervention group
Group type: COMPARATOR
Intervention: Cy/GVAX followed by CRS-207 without nivolumab (Arm B)
Number of subjects: 93
Study 32273276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cy/GVAX followed by CRS-207 (Arm A)
Number of subjects: 93
Study 32273276 — intervention group
Group type: COMPARATOR
Intervention: Cy/GVAX followed by CRS-207 (Arm B)
Number of subjects: 93
Study 34984660 — intervention group
Group type: EXPERIMENTAL
Intervention: Faith-based group education and motivational interviewing intervention
Number of subjects: 0
Study 34984660 — intervention group
Group type: COMPARATOR
Intervention: Delayed group (control)
Number of subjects: 0
Study 34113435 — intervention group
Group type: COMPARATOR
Intervention: Modular intervention to improve paternal involvement in infant and young child feeding (IYCF); implemented through monthly visits for six months.
Number of subjects: 120
Study 34113435 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned); participants receive standard care without the modular intervention.
Number of subjects: 120
Study 32423247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal steroids (Nasacort)
Number of subjects: 42
Study 32423247 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Ayr saline spray)
Number of subjects: 42
Study 32423247 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 42
Study 36205265 — intervention group
Group type: EXPERIMENTAL
Intervention: SpHb measurement
Number of subjects: 120
Study 34510448 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical parasagittal hemispherotomy
Number of subjects: 672
Study 34510448 — intervention group
Group type: COMPARATOR
Intervention: Lateral peri-insular/peri-Sylvian or trans-Sylvian hemispherotomy
Number of subjects: 672
Study 34510448 — intervention group
Group type: COMPARATOR
Intervention: Lateral hemispherotomy technique
Number of subjects: 672
Study 32461526 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate high-monounsaturated fatty acid (LC/HM) formula
Number of subjects: 10
Study 32461526 — intervention group
Group type: COMPARATOR
Intervention: Standard control formula
Number of subjects: 10
Study 34690272 — intervention group
Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 74